News
TherapeuticsMD
TXMD · NASDAQ
$1.88+$0.02 (+1.08%)TodayMarket closed ·
Prev close $1.86
Latest news
- Press releaseBusiness Wire
TherapeuticsMD Announces Second Quarter 2026 Financial Results
- News
TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY
- Press releaseBusiness Wire
TherapeuticsMD Announces First Quarter 2026 Financial Results
- News
TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY
- Press releaseBusiness Wire
TherapeuticsMD Announces Full Year 2025 Financial Results
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseBusiness Wire
TherapeuticsMD Announces Third Quarter 2025 Financial Results
- News
TherapeuticsMD Q2 EPS $0.05 Up From $(0.09) YoY, Sales $1.000M Up From $234.000K YoY
- Press releaseBusiness Wire
TherapeuticsMD Announces Second Quarter 2025 Financial Results
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- Press releaseBusiness Wire
TherapeuticsMD Announces Full Year 2024 Financial Results
- NewsAvi Kapoor
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
- Press releaseBusiness Wire
TherapeuticsMD Announces Third Quarter 2024 Financial Results
- NewsAvi Kapoor
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
- Press releaseBusiness Wire
TherapeuticsMD Announces Second Quarter 2024 Financial Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.